Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases Journal Article


Authors: Correa-Gallego, C.; Gonen, M.; Fischer, M.; Grant, F.; Kemeny, N. E.; Arslan Carlon, V.; Kingham, T. P.; DeMatteo, R. P.; Fong, Y.; Allen, P. J.; D'Angelica, M. I.; Jarnagin, W. R.
Article Title: Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases
Abstract: Background: Perioperative outcomes, such as blood loss, transfusions, and morbidity, have been linked to cancer-specific survival, but this is largely unsupported by prospective data. Methods: Patients from a previous, randomized trial that evaluated acute normovolemic hemodilution during major hepatectomy (≥3 segments) were reevaluated and those with metastatic colorectal cancer (n = 90) were selected for analysis. Survival data were obtained from the medical record. Disease extent was measured using a clinical-risk score (CRS). Log-rank test and Cox proportional hazard model were used to evaluate recurrence-free survival (RFS) and overall survival (OS). Results: Median follow-up was 71 months. The CRS was ≥3 in 45 % of patients; 59 % had extrahepatic procedures. Morbidity and mortality were 33 and 2 %, respectively. Postoperative chemotherapy was given to 87 % of patients (78/90) starting at a median of 6 weeks. RFS and OS were 29 and 60 months, respectively. Postoperative morbidity significantly reduced RFS (23 vs. 69 months; P < 0.001) and OS (28 vs. 74 months; P < 0.001) on uni- and multi-variate analysis; positive resection margins and high CRS also were significant factors. Delayed initiation of postoperative chemotherapy (≥8 weeks) was common in patients with complications (37 vs. 12 %; P = 0.01). Conclusions: In this selected cohort of patients from a previous RCT, perioperative morbidity was strongly (and independently) associated with cancer-specific outcome. It also was associated with delayed initiation of postoperative chemotherapy, the impact of which on survival is unclear. © 2013 Society of Surgical Oncology.
Journal Title: Annals of Surgical Oncology
Volume: 20
Issue: 8
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2013-08-01
Start Page: 2477
End Page: 2484
Language: English
DOI: 10.1245/s10434-013-2975-9
PROVIDER: scopus
PUBMED: 23608971
DOI/URL:
Notes: --- - "Export Date: 1 August 2013" - "CODEN: ASONF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary Ellen Fischer
    30 Fischer
  2. Florence Grant
    15 Grant
  3. Ronald P DeMatteo
    637 DeMatteo
  4. Mithat Gonen
    1029 Gonen
  5. Peter Allen
    501 Allen
  6. William R Jarnagin
    903 Jarnagin
  7. Yuman Fong
    775 Fong
  8. T Peter Kingham
    609 Kingham
  9. Nancy Kemeny
    543 Kemeny
  10. Juan Camilo Correa
    30 Correa